Shifting Trends in the Indication of Glucagon-like Peptide-1 Receptor Agonist Prescriptions: A Nationwide Analysis
2024 · Annals of Internal Medicine · 64 citations
https://doi.org/10.7326/m24-0019
G
Ghada Mohamed
Cairo University(EG)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
72
Papers
569
Citations
12
h-index
13
i10-index
Ghada Mohamed is an academic researcher from Cairo University. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Radiomics and Machine Learning in Medical Imaging & Breast Cancer Treatment Studies. The author has an h-index of 12, co-authored 62 publications.
ORCID: 0000-0002-5831-4083Papers by this author
worksShifting Trends in the Indication of Glucagon-like Peptide-1 Receptor Agonist Prescriptions: A Nationwide Analysis
2024 · Annals of Internal Medicine · 64 citations
https://doi.org/10.7326/m24-0019
Prognostic Significance of Serum Vitamin D Levels in Egyptian Females with Breast Cancer
2018 · PubMed · 31 citations
https://doi.org/10.22034/apjcp.2018.19.2.571
Role of artificial intelligence –based machine learning model in predicting HER2/neu gene status in breast cancer
2025 · Pathology - Research and Practice · 3 citations
https://doi.org/10.1016/j.prp.2025.155927
Mo1135 MODIFIABLE LONG-TERM RISK FACTORS THAT PREDICT FUTURE DEVELOPMENT OF COLORECTAL CANCER (CRC): RESULTS FROM LARGE EPIDEMIOLOGICAL DATA
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)02654-4
Tu1405 UPFRONT SURGICAL RESECTION IS SUPERIOR TO NEOADJUVANT THERAPY FOLLOWED BY SURGERY (NATS) FOR STAGE I PANCREATIC DUCTAL ADENOCARCINOMA (PDAC): SURVIVAL ANALYSIS OF THE NATIONAL CANCER DATABASE (NCDB) (2004 - 2020)
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)03495-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat